The bargain gives Pfizer legal rights to establish and market a medication from Shenyang-based 3SBio. The firm pays USD 1.25 bn upfront.
发布者：BY KRISTOFFER GRONBAEK，转转请注明出处：https://robotalks.cn/pfizer-licenses-3sbio-cancer-drug-for-record-usd-1-25bn/
Pfizer licenses 3SBio cancer drug for record USD 1.25bn
赞 (0)
关于作者
Novo Nordisk should consider finding CEO in the US, analysts say
上一篇
25 5 月, 2025 1:19 上午
Over 100 countries vote for global pandemic agreement
下一篇
25 5 月, 2025 1:19 上午
相关推荐
-
Coloplast “strongly disagrees” with verdict on abuse of dominant position in Denmark
Danish competitors authority states that Coloplast’s Danish service has actually abused its leading placement to press rivals out of the marketplace for the sale of ostomy de…
-
The Bot Brief
POSTED 01/26/2025 v> “There may per chance be no such thing as a pressure on earth extra extremely efficient than a belief whose time has method.” Victor Hugo Bots in the News: In the abbreviated shopping and selling week, the Bot Index jumped 2.82%, beating the S & P 500 by 107 foundation
-
Opinion: The mining executive order needs creative financial support to achieve its goals
The Trump Management’s recently released exec order (EO) ” Immediate Actions to Enhance American Mineral Manufacturing” routes government companies to take action…
-
Google ‘anti-competitive’ over online ad tech: UK
US tech titan Google employs “anti-competitive practices” with regards to online advertising, Britain’s competition watchdog concluded Friday in provisional findi…
-
Amid ban uncertainty, TikTok’s role in brands’ social presences has decreased
Also if TikTok locates a course ahead in the united state, brand names and companies that were formerly concentrated on the system have actually discovered that this technique is a…
